- Home
- BBIO vs RIVN Comparison
BBIO vs RIVN Comparison
Compare BBIO & RIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBIO | RIVN |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 18.3B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BBIO | RIVN |
|---|---|---|
| Price | $73.82 | $15.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 24 | 21 |
| Target Price | ★ $85.43 | $17.74 |
| AVG Volume (30 Days) | 1.6M | ★ 24.2M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.54 |
| EPS | N/A | ★ N/A |
| Revenue | $502,076,000.00 | ★ $5,387,000,000.00 |
| Revenue This Year | $88.16 | $32.97 |
| Revenue Next Year | $74.13 | $64.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 126.26 | 8.39 |
| 52 Week Low | $30.08 | $10.85 |
| 52 Week High | $84.94 | $22.69 |
Technical Indicators
Market Signals| Indicator | BBIO | RIVN |
|---|---|---|
| Relative Strength Index (RSI) | 56.58 | 47.03 |
| Support Level | $69.62 | $14.20 |
| Resistance Level | $78.20 | $17.80 |
| Average True Range (ATR) | 2.66 | 0.87 |
| MACD | 0.41 | -0.03 |
| Stochastic Oscillator | 78.53 | 26.22 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About RIVN Rivian Automotive Inc.
Rivian is a battery electric vehicle automaker that sells its vehicles in the US and Canada. The company also develops electronic control units and related software for autos in a joint venture with Volkswagen. Rivian has multiple vehicles in its fleet, which include a luxury truck and full-size SUV and a delivery van. The company plans to begin selling a midsize SUV in 2026. Total deliveries were over 42,000 in 2025. Rivian is also developing autonomous driving software to be used in its vehicles.